Q3 2024 · 13F-HR
Athyrium Capital Management, LPholdings as filed
Filed 2024-11-12 · accession 0001123292-24-000336
$8.7M
Reported value
2
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 74319F305 | — | Biora Therapeutics Inc. | $5.5M | 63.1% | 10,929,762 | Common | SOLE |
| 74587V107 | PBYI | PUMA BIOTECHNOLOGY INC | $3.2M | 36.9% | 1,256,411 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.